These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30814691)

  • 1. Advances in antibody engineering for rheumatic diseases.
    Schmid AS; Neri D
    Nat Rev Rheumatol; 2019 Apr; 15(4):197-207. PubMed ID: 30814691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic agents in the therapy of inflammatory rheumatic diseases, including therapeutic antibodies, cytokines, and cytokine antagonists.
    Kalden JR
    Curr Opin Rheumatol; 1994 May; 6(3):281-6. PubMed ID: 8060762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1997 May; 9(3):206-12. PubMed ID: 9204255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic treatments for systemic rheumatic diseases.
    Shirota Y; Illei GG; Nikolov NP
    Oral Dis; 2008 Apr; 14(3):206-16. PubMed ID: 18282173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic therapies in rheumatology: lessons learned, future directions.
    Strand V; Kimberly R; Isaacs JD
    Nat Rev Drug Discov; 2007 Jan; 6(1):75-92. PubMed ID: 17195034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New structural formats of therapeutic antibodies for rheumatology.
    Dumet C; Pottier J; Gouilleux V; Watier H
    Joint Bone Spine; 2018 Jan; 85(1):47-52. PubMed ID: 28461199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal and monoclonal antibodies in clinic.
    Wootla B; Denic A; Rodriguez M
    Methods Mol Biol; 2014; 1060():79-110. PubMed ID: 24037837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic advances in rheumatology with the use of recombinant proteins.
    Rothe A; Power BE; Hudson PJ
    Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-interleukin-6 receptor antibody therapy in rheumatic diseases.
    Nakahara H; Nishimoto N
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):373-81. PubMed ID: 17214583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1998 May; 10(3):174-8. PubMed ID: 9608318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatology].
    Scherer HU; Burmester GR
    Internist (Berl); 2005 Aug; 46(8):882-91. PubMed ID: 15997385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells as therapeutic targets for rheumatic diseases.
    Looney RJ; Anolik J; Sanz I
    Curr Opin Rheumatol; 2004 May; 16(3):180-5. PubMed ID: 15103242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1995 May; 7(3):191-7. PubMed ID: 7612410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progression and direction of humanized antibody research].
    Lin Y; Yan XY
    Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):1-5. PubMed ID: 16108479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the binding sites of anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab.
    Kosmač M; Avčin T; Toplak N; Simonini G; Cimaz R; Curin Šerbec V
    Pediatr Res; 2011 Mar; 69(3):243-8. PubMed ID: 21131896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody therapy of inflammatory rheumatic diseases.
    Breedveld FC; van der Lubbe PA
    Br Med Bull; 1995 Apr; 51(2):493-502. PubMed ID: 7552078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological therapies in rheumatic diseases.
    Conti F; Ceccarelli F; Massaro L; Cipriano E; Di Franco M; Alessandri C; Spinelli FR; Scrivo R
    Clin Ter; 2013; 164(5):e413-28. PubMed ID: 24217844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible reactivation of potential hepatitis B virus occult infection by tumor necrosis factor-alpha blocker in the treatment of rheumatic diseases.
    Kim YJ; Bae SC; Sung YK; Kim TH; Jun JB; Yoo DH; Kim TY; Sohn JH; Lee HS
    J Rheumatol; 2010 Feb; 37(2):346-50. PubMed ID: 20008922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.